1. Home
  2. RPTX vs XNET Comparison

RPTX vs XNET Comparison

Compare RPTX & XNET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPTX
  • XNET
  • Stock Information
  • Founded
  • RPTX 2016
  • XNET 2003
  • Country
  • RPTX Canada
  • XNET China
  • Employees
  • RPTX N/A
  • XNET N/A
  • Industry
  • RPTX Biotechnology: Pharmaceutical Preparations
  • XNET Computer Software: Prepackaged Software
  • Sector
  • RPTX Health Care
  • XNET Technology
  • Exchange
  • RPTX Nasdaq
  • XNET Nasdaq
  • Market Cap
  • RPTX 152.4M
  • XNET 131.8M
  • IPO Year
  • RPTX 2020
  • XNET 2014
  • Fundamental
  • Price
  • RPTX $2.97
  • XNET $1.86
  • Analyst Decision
  • RPTX Strong Buy
  • XNET
  • Analyst Count
  • RPTX 1
  • XNET 0
  • Target Price
  • RPTX $10.00
  • XNET N/A
  • AVG Volume (30 Days)
  • RPTX 113.0K
  • XNET 122.8K
  • Earning Date
  • RPTX 11-07-2024
  • XNET 11-14-2024
  • Dividend Yield
  • RPTX N/A
  • XNET N/A
  • EPS Growth
  • RPTX N/A
  • XNET 23.02
  • EPS
  • RPTX N/A
  • XNET 0.23
  • Revenue
  • RPTX $66,524,000.00
  • XNET $316,007,000.00
  • Revenue This Year
  • RPTX $13.36
  • XNET N/A
  • Revenue Next Year
  • RPTX N/A
  • XNET N/A
  • P/E Ratio
  • RPTX N/A
  • XNET $8.33
  • Revenue Growth
  • RPTX 18.19
  • XNET N/A
  • 52 Week Low
  • RPTX $2.71
  • XNET $1.45
  • 52 Week High
  • RPTX $8.49
  • XNET $2.41
  • Technical
  • Relative Strength Index (RSI)
  • RPTX 39.57
  • XNET 43.93
  • Support Level
  • RPTX $2.81
  • XNET $2.01
  • Resistance Level
  • RPTX $4.05
  • XNET $1.98
  • Average True Range (ATR)
  • RPTX 0.27
  • XNET 0.10
  • MACD
  • RPTX -0.08
  • XNET -0.03
  • Stochastic Oscillator
  • RPTX 16.92
  • XNET 9.59

About RPTX Repare Therapeutics Inc.

Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.

About XNET Xunlei Limited

Xunlei Ltd is a cloud-based acceleration technology company in China. The company operates a powerful internet platform in China based on cloud computing to provide users with quick and easy access to digital media content through its products and services, Xunlei Accelerator, and cloud acceleration subscription services. It is increasingly extending into mobile devices in part through potentially pre-installed acceleration products in mobile phones Xunlei has developed various value-added services to meet a fuller spectrum of its users' digital media content access and consumption needs.

Share on Social Networks: